Amylin (AMLN), Lilly (LLY) Get FDA Approval for BYETTA Use as Add-On to Insulin in Certain Cases
Go back to Amylin (AMLN), Lilly (LLY) Get FDA Approval for BYETTA Use as Add-On to Insulin in Certain Cases| Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) | Delayed: 30.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.98 | 52 Week High | $31.02 | |||
| Open | $3.30 | 52 Week Low | $8.03 | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $30.98 | EPS | $-4.38 | |||
| Volume | 440,704 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1255.40 +11.00 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1244.40 | 52 Week High | $88.16 | |||
| Open | $1232.00 | 52 Week Low | $67.88 | |||
| Day High | $1271.22 | P/E | 290.60 | |||
| Day Low | $1230.00 | EPS | $4.32 | |||
| Volume | 2,505,585 | |||||
